Meet Our Bariatric Surgeon Dr. David Davtyan
Board certified by the American Board of Surgery and a diplomate of the American Board of Obesity Medicine, Dr. David G. Davtyan is a weight loss surgeon in Los Angeles. He has a deeply personal understanding of his patients’ weight loss challenges. His empathy puts his patients at ease and makes them feel immensely comfortable as they embark on the exciting journey to lose weight and reclaim their health.
A California physician since 1990 and certified by the American Board of Surgery since 1997, Dr. Davtyan completed LAP-BAND System training from October 2001 through May 2002, after its June 2001 FDA approval.
Dr. Davtyan has described having a LAP-BAND placed in Brussels in October 2001 (OH Magazine, 2006).
His fellowship training in surgical oncology shaped how he follows patients. Because cancer can come back, he is accustomed to careful, long-term follow-up, and he continues to offer that to his bariatric patients.
Credentials You Can Check Yourself
- American Board of Surgery: certified in Surgery (General Surgery), certificate #041985, first certified February 11, 1997. The Board lists his status as "Certified" and "Meeting CC Requirements," valid to December 31, 2027. Check it at the American Board of Surgery. Checked November 2026.
- California medical license: G 70030. Look up status and any public actions at the Medical Board of California.
- National Provider Identifier: 1184647729. See the federal NPI record.
- Medical degree: UCLA School of Medicine, May 21, 1989.
- Fellowships (certificates shown): American College of Surgeons (2002), International College of Surgeons (1997), American Society for Metabolic and Bariatric Surgery (2024). See the certificates.
Training
- 1985-1989: UCLA School of Medicine, MD
- 1989-1990: Intern in general surgery, University of Texas Medical School at Houston and MD Anderson Cancer Center
- 1990-1991: Postdoctoral study in surgical oncology, UCLA Department of Surgery
- 1991-1992: Clinical Fellow in Surgical Oncology, John Wayne Cancer Institute
- 1992-1996: Resident, then Chief Resident (1995-1996), general surgery, University of Texas Medical School at Houston
- 1996-1997: Surgical Oncology Fellowship, John Wayne Cancer Institute
- February 2001: Minimally Invasive Surgery for Morbid Obesity (continuing education), University of Pittsburgh School of Medicine, Snowbird, Utah
- May 2002: LAP-BAND System workshop, Tijuana, certificate from Inamed/BioEnterics
Peer-Reviewed Publications Indexed in PubMed
- Dickey J, Davtyan C, Davtyan D, Taegtmeyer H. Homeostasis Disrupted and Restored-A Fresh Look at the Mechanism and Treatment of Obesity During COVID-19. Front Cardiovasc Med. 2021;8:721956. PubMed 34513959
- Morton DL, Davtyan DG, Wanek LA, Foshag LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer. 1993;71(11):3737-43. PubMed 8490924
- Morton DL, Foshag LJ, Hoon DS, Nizze JA, Famatiga E, Wanek LA, Chang C, Davtyan DG, Gupta RK, Elashoff R. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg. 1992;216(4):463-82. PubMed 1417196
- Davtyan DG, Vinters HV. Wernicke's encephalopathy in AIDS patient treated with zidovudine. Lancet. 1987;1(8538):919-20. PubMed 2882316
Other writing: Davtyan CA, Davtyan DG, Consultant, 2004; Davtyan CA, Davtyan DG, The Female Patient, 2003 (reprint). Co-signer, group letter, General Surgery News, 2017.









More About Dr. Davtyan
His full education, continuing education, lectures and service are on his curriculum vitae. Interviews are on the media page.





